Trader consensus prices "No" at 84.5% for a new COVID-19 variant of concern before 2027, driven by the absence of any SARS-CoV-2 strain meeting WHO criteria for VOC status since Omicron years ago, as confirmed in ECDC's April 13 update listing zero VOCs. Robust global genomic surveillance, including WHO's CoViNet and CDC wastewater monitoring, has tracked rising BA.3.2 ("Cicada") detections in over 30 U.S. states and Europe since late 2025, yet it remains a Variant Under Monitoring due to no evidence of heightened transmissibility, severity, or vaccine evasion beyond population immunity levels. Endemic circulation of Omicron sublineages like XFG and low overall case rates reinforce this stability, with annual vaccine updates mitigating risks through year-end.